Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyril B Dousson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Antiviral Chemistry & Chemotherapy|February 22, 2018
Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infectionCyril B Dousson
Antiviral Research|May 8, 2020
HBV replication inhibitorsClaire Pierra Rouviere, Cyril B Dousson, John E Tavis
Journal of Medicinal Chemistry|September 29, 2018
Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4'-Ethynyl-2-fluoro-2'-deoxyadenosine)François-René Alexandre, Rachid Rahali, Houcine Rahali, et al.
Journal of Medicinal Chemistry|December 15, 2010
Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitorsFrançois-René Alexandre, Agnès Amador, Stéphanie Bot, et al.
Bioorganic & Medicinal Chemistry Letters|April 19, 2017
Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitorJean-Laurent Paparin, Agnès Amador, Eric Badaroux, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2017
The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitorsFrançois-René Alexandre, Eric Badaroux, John P Bilello, et al.
Journal of Medicinal Chemistry|March 22, 2007
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseAndrew A Mortlock, Kevin M Foote, Nicola M Heron, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Antiviral Chemistry & Chemotherapy|February 22, 2018
Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infectionCyril B Dousson
Antiviral Research|May 8, 2020
HBV replication inhibitorsClaire Pierra Rouviere, Cyril B Dousson, John E Tavis
Journal of Medicinal Chemistry|September 29, 2018
Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4'-Ethynyl-2-fluoro-2'-deoxyadenosine)François-René Alexandre, Rachid Rahali, Houcine Rahali, et al.
Journal of Medicinal Chemistry|December 15, 2010
Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitorsFrançois-René Alexandre, Agnès Amador, Stéphanie Bot, et al.
Bioorganic & Medicinal Chemistry Letters|April 19, 2017
Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitorJean-Laurent Paparin, Agnès Amador, Eric Badaroux, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2017
The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitorsFrançois-René Alexandre, Eric Badaroux, John P Bilello, et al.
Journal of Medicinal Chemistry|March 22, 2007
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseAndrew A Mortlock, Kevin M Foote, Nicola M Heron, et al.
Pageof 1